State Ledger
Company profile

PharmaCyte Biotech, Inc. CIK 1157075

Ticker
PMCB (Nasdaq)
Industry
Biological Products, (No Diagnostic Substances)
Headquarters
Las Vegas, NV 89169
Fiscal year end
2026 (FY)
Market Data
Close
$0.40
Change
+$0.00
Change %
0.00%
Volume
0

PMCB · trading date Oct 9, 2026 · previous close $0.40 · source: Alpaca (IEX feed, not consolidated full-market data).

Key Financials
Revenue
$0
Net income
-$19.42M
Total assets
$46.75M
Total liabilities
$11.77M
Stockholders' equity
$33.29M
Cash & equivalents
$18.60M
Operating income
-$6.85M
Operating cash flow
-$5.15M
Capital expenditures
—

Fiscal year 2026, via 10-K filed 2026-07-29. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.

Financial Performance
Operating margin
—
Net margin
—
Free cash flow
—
Free cash flow margin
—
Liabilities / assets
25.2%
Equity / assets
71.2%
CapEx / revenue
—
Operating cash flow / net income
0.27×

Derived from the fiscal year 2026 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.

Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2026 $0 -$19.42M $46.75M $11.77M $33.29M
2025 $0 $30.66M $55.17M $3.28M $51.89M
2024 $0 $333.8K $59.90M $20.39M $27.65M
2023 $0 -$4.32M $73.28M $586.6K $72.69M
2022 $0 -$4.24M $90.62M $704.4K $89.92M
Company Details
SIC code
2836
State of incorporation
NV
Active filer
Yes
Most recent SEC filing
Form 10-Q
2026-09-14
Financials filed via
Form 10-K
filed 2026-07-29

"Most recent SEC filing" may differ from the filing used for the financial figures above.

Location
Las Vegas, NV 89169
3960 HOWARD HUGHES PARKWAY
Data & Methodology

SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:38 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.

← Back to Nevada — Public Companies